Effect of panchtikta ksheera basti and asthi sandhaniya dravya siddh basti in the management of fragileness of bone(Asthi Kshaya)

A comparative clinical study of panchtikta ksheera basti and Asthi Sandhaniya Dravya siddh ksheera Basti in Asthi kshaya (osteoporosis)

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/01/022766

Enrollment

Registered

2020-01-15

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M810- Age-related osteoporosis without current pathological fracture

Interventions

Intervention1: Panchtikta ksheera basti: Basti karma on daily for 16 day Control Intervention1: Asthi Sandhaniya Dravya siddh ksheera basti: Basti karma on daily 16 days

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients will be selected between the age group of 40-70 years. 2. Patient representing with classical features of asthikshaya. 3. Patient of both sex are taken. 4. Patient of osteoporosis diagnosed by BMD test.

Exclusion criteria

Exclusion criteria: 1. Patient below the age of 40 and above 70 years. 2. Patient suffering from any systemic disorder like DM, HTN, Endocrinal disorders, Pagetâ??s disease, Cushing syndrome etc. 3. Patient suffering from pathological osteoporosis or any neoplasm or osteoporosis related to systemic disorders. 4. Osteoporosis associated with fracture.

Design outcomes

Primary

Measure	Time frame
Improvement in subjective and objective parameterTimepoint: 1 month	—

Secondary

Measure	Time frame
To find the comparative efficacy of the treatments in different groupsTimepoint: 1 month	—

Countries

India

Contacts

Public ContactDr Sunita bola

Dr sarvapalli Radhakrishnan Rajasthan ayurved university college of jodhpur

atreyagyan@gmail.com9829798701

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026